UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000057527 |
|---|---|
| Receipt number | R000065726 |
| Scientific Title | Predicting response to individualized occupational therapy for schizophrenia: Data from a randomized controlled study |
| Date of disclosure of the study information | 2025/04/07 |
| Last modified on | 2025/04/05 20:15:19 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Predicting response to individualized occupational therapy for schizophrenia: Data from a randomized controlled study
Acronym
Predicting response to individualized occupational therapy for schizophrenia
Scientific Title
Predicting response to individualized occupational therapy for schizophrenia: Data from a randomized controlled study
Scientific Title:Acronym
Predicting response to individualized occupational therapy for schizophrenia
Region
| Japan |
Condition
Condition
schizophrenia
Classification by specialty
| Psychiatry | Rehabilitation medicine |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Identifying the factors that improvement with individualized occupational therapy (IOT) could be important to improve its efficacy by personalizing and tailoring treatment to different patient profiles. This study aimed to investigate of factors that predict response to IOT for patients with schizophrenia.
Basic objectives2
Others
Basic objectives -Others
Identifying the factors that improvement with individualized occupational therapy (IOT) could be important to improve its efficacy by personalizing and tailoring treatment to different patient profiles. This study aimed to investigate of factors that predict response to IOT for patients with schizophrenia.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Demographics
BACS
QLS
EQ-5D-5L
LASMI
PANSS
mGAF-F
Key secondary outcomes
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 60 | years-old | > |
Gender
Male and Female
Key inclusion criteria
(1) diagnosed with schizophrenia based on DSM-5
Key exclusion criteria
(1) a current primary DSM-5 diagnosis other than schizophrenia
(2) a history of mental retardation
(3) a history of neurological disorder
(4) a history of significant drug or alcohol abuse
(5) current risk of suicide, or a history of suicidal behavior within 6 months prior to consent
(6) comorbid serious physical disorder
Target sample size
116
Research contact person
Name of lead principal investigator
| 1st name | Takeshi |
| Middle name | |
| Last name | Shimada |
Organization
Medical Corporation Seitaikai Mental Support Soyokaze Hospital
Division name
Department of Rehabilitation
Zip code
3860401
Address
3057-1, Shiogawa, Ueda, Nagano, Japan
TEL
0268350305
ot@seitaikai.or.jp
Public contact
Name of contact person
| 1st name | Takeshi |
| Middle name | |
| Last name | Shiamda |
Organization
Medical Corporation Seitaikai Mental Support Soyokaze Hospital
Division name
Department of Rehabilitation
Zip code
3860401
Address
3057-1, Shiogawa, Ueda, Nagano, Japan
TEL
0268350305
Homepage URL
ot@seitaikai.or.jp
Sponsor or person
Institute
Medical Corporation Seitaikai Mental Support Soyokaze Hospital
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Medical Corporation Seitaikai Mental Support Soyokaze Hospital
Address
3057-1, Shiogawa, Ueda, Nagano, Japan
Tel
0268350305
ot@seitaikai.or.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 04 | Month | 07 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
62
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2020 | Year | 10 | Month | 21 | Day |
Date of IRB
| 2020 | Year | 10 | Month | 21 | Day |
Anticipated trial start date
| 2021 | Year | 01 | Month | 01 | Day |
Last follow-up date
| 2025 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
secondary analysis
Management information
Registered date
| 2025 | Year | 04 | Month | 05 | Day |
Last modified on
| 2025 | Year | 04 | Month | 05 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065726
